세계의 이부프로펜 API 시장

Global Ibuprofen API Market to Reach US$807.8 Million by 2030

The global market for Ibuprofen API estimated at US$765.5 Million in the year 2024, is expected to reach US$807.8 Million by 2030, growing at a CAGR of 0.9% over the analysis period 2024-2030. Arthritis Application, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$392.0 Million by the end of the analysis period. Growth in the Headache Application segment is estimated at 0.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$201.2 Million While China is Forecast to Grow at 0.7% CAGR

The Ibuprofen API market in the U.S. is estimated at US$201.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$129.6 Million by the year 2030 trailing a CAGR of 0.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 0.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 0.2% CAGR.

Global Ibuprofen API Market - Key Trends & Drivers Summarized

What Drives the Demand for Ibuprofen API Across Industries?

The ibuprofen API market continues to expand, fueled by a combination of medical, industrial, and demographic factors that collectively increase its utility and consumption. Rising global healthcare expenditures, especially in emerging economies, have significantly boosted the demand for non-steroidal anti-inflammatory drugs (NSAIDs), with ibuprofen being a key contender due to its proven efficacy and safety profile. The aging population worldwide, particularly in North America, Europe, and parts of Asia, is contributing to a surge in chronic pain and inflammation-related disorders, which rely heavily on ibuprofen-based therapies. Furthermore, the pharmaceutical industry’s focus on increasing access to essential medicines in underserved regions has elevated the importance of ibuprofen API as a staple drug ingredient. Beyond medical applications, the demand is also rising in veterinary medicine, where ibuprofen is used in managing pain and inflammation in animals, further diversifying its market base.

How Are Technological Innovations Shaping the Market?

The ibuprofen API market has witnessed a revolution in its production methodologies, driven by advancements in pharmaceutical manufacturing technologies. Continuous manufacturing processes, supported by automation and real-time monitoring systems, have significantly enhanced the efficiency, scalability, and quality consistency of ibuprofen production. These innovations have reduced production costs and minimized errors, ensuring compliance with stringent regulatory standards. Another notable trend is the integration of green chemistry principles into production processes. Manufacturers are adopting environmentally friendly methods, such as water-efficient synthesis, solvent recycling, and the use of biodegradable raw materials, to align with global sustainability goals. Moreover, research and development efforts are unlocking innovative formulations of ibuprofen with improved bioavailability and reduced side effects, catering to an increasingly health-conscious consumer base. These advancements are critical in maintaining the competitive edge of leading players while paving the way for new entrants to adopt sustainable practices and gain market share.

What Regional and Sectoral Trends Define the Ibuprofen API Market?

The regional dynamics of the ibuprofen API market reveal a clear divide between production and consumption centers, with Asia-Pacific emerging as the leading producer due to its robust pharmaceutical manufacturing infrastructure. India and China dominate this landscape, supported by government incentives, abundant raw materials, and skilled labor forces. These countries are also capitalizing on their cost advantages to supply APIs to North America, Europe, and other high-consumption markets. On the other hand, developed regions such as North America and Europe drive the demand for high-quality ibuprofen APIs, fueled by advanced healthcare systems and the widespread prevalence of chronic diseases like arthritis, cardiovascular conditions, and diabetes. Additionally, the expansion of the e-commerce sector has accelerated the growth of over-the-counter sales of ibuprofen-based products, particularly in urban areas where consumers demand quick and convenient access to medications. As rural healthcare infrastructure develops in emerging economies, the demand for ibuprofen API is expected to penetrate previously untapped markets.

What Factors Are Driving the Growth of the Ibuprofen API Market?

The growth in the Ibuprofen API market is driven by several factors directly linked to advancements in technology, end-use applications, and shifting consumer behavior. One of the most critical drivers is the increasing prevalence of inflammatory and pain-related conditions, a byproduct of aging populations and sedentary lifestyles. This is compounded by the rising incidence of surgical procedures globally, which often necessitate post-operative pain management solutions, further boosting ibuprofen demand. Technological advancements in pharmaceutical manufacturing, including process automation and quality monitoring, have streamlined production, ensuring the consistent availability of high-grade APIs. Additionally, the pharmaceutical industry has witnessed an uptick in R&D investments, leading to novel ibuprofen formulations tailored to address specific medical needs such as faster onset of action and reduced gastrointestinal side effects. On the consumer front, the trend toward self-medication and over-the-counter drug purchases has surged, supported by better-informed individuals seeking cost-effective and readily available solutions for common ailments. Online pharmacies and the digitization of healthcare distribution channels have further simplified access, broadening the market’s reach. Altogether, these interconnected factors underscore the growing prominence of ibuprofen API in addressing evolving healthcare demands globally.

SCOPE OF STUDY:

The report analyzes the Ibuprofen API market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Arthritis Application, Headache Application, Other Applications); End-Use (Pharma & Biopharma Companies End-Use, Clinical Research Organizations & CMOs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

• Abbott Laboratories, Inc.
• Anantco Enterprises Pvt. Ltd.
• BASF SE
• Dr. Reddy's Laboratories Ltd.
• Granules India Limited.
• Iol Chemicals & Pharmaceutical
• LGM Pharma
• Octavius Pharma Pvt. Ltd.
• Pfizer, Inc.
• Rochem International Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Economic Frontiers: Trends, Trials & Transformations
  • Ibuprofen API - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Over-the-Counter (OTC) Pain Relief Fuels Growth in Ibuprofen API Production
  • Increased Prevalence of Chronic Pain Conditions Drives Demand for Ibuprofen APIs
  • Expansion of Generic Drug Manufacturing Strengthens Market for Ibuprofen APIs
  • Focus on Affordable Healthcare Fuels Growth in Ibuprofen API Demand Globally
  • Advancements in API Manufacturing Processes Propel Cost-Efficiency and Market Growth
  • Stringent Quality Regulations Highlight the Need for Compliance in Ibuprofen API Production
  • Focus on Sustainable and Green Chemistry Drives Innovation in API Manufacturing
  • Rising Global Pharmaceutical Outsourcing Creates Opportunities for Ibuprofen API Producers
  • Growth in Emerging Markets Spurs Demand for Cost-Effective Ibuprofen APIs
  • Focus on Combating Counterfeit APIs Strengthens Quality Standards in Ibuprofen Production
  • Increased Adoption of Pain Management Therapies Expands Ibuprofen API Applications
  • Focus on Fast-Acting and Extended-Release Formulations Enhances Demand for High-Quality APIs
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Ibuprofen API Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Ibuprofen API by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for Ibuprofen API by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Arthritis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Arthritis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Headache Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for Headache Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World 6-Year Perspective for Pharma & Biopharma Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Clinical Research Organizations & CMOs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 13: World 6-Year Perspective for Clinical Research Organizations & CMOs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Ibuprofen API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 14: USA Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 15: USA 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 16: USA Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 17: USA 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• CANADA
  • TABLE 18: Canada Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 19: Canada 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 20: Canada Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 21: Canada 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• JAPAN
  • Ibuprofen API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 22: Japan Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 23: Japan 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 24: Japan Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 25: Japan 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• CHINA
  • Ibuprofen API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 26: China Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: China 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 28: China Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 29: China 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• EUROPE
  • Ibuprofen API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 30: Europe Recent Past, Current & Future Analysis for Ibuprofen API by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 31: Europe 6-Year Perspective for Ibuprofen API by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 32: Europe Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Europe 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 34: Europe Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 35: Europe 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• FRANCE
  • Ibuprofen API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 36: France Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 37: France 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 38: France Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: France 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• GERMANY
  • Ibuprofen API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 40: Germany Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 41: Germany 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 42: Germany Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 43: Germany 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• ITALY
  • TABLE 44: Italy Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Italy 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 46: Italy Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 47: Italy 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• UNITED KINGDOM
  • Ibuprofen API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 48: UK Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 49: UK 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 50: UK Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: UK 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 53: Rest of Europe 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 55: Rest of Europe 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• ASIA-PACIFIC
  • Ibuprofen API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Asia-Pacific 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 59: Asia-Pacific 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Ibuprofen API by Application - Arthritis Application, Headache Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 61: Rest of World 6-Year Perspective for Ibuprofen API by Application - Percentage Breakdown of Value Sales for Arthritis Application, Headache Application and Other Applications for the Years 2025 & 2030
  • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Ibuprofen API by End-Use - Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Rest of World 6-Year Perspective for Ibuprofen API by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies End-Use and Clinical Research Organizations & CMOs End-Use for the Years 2025 & 2030

IV. COMPETITION